![J6I J6I](https://data.pdbj.org/pdbjplus/data/cc/svg/J6I.svg) | J6I | Name: | 2-amino-4-{[(1S)-cyclohex-2-en-1-yl]oxy}quinoline-3-carbonitrile | Formula: | C16 H15 N3 O | SMILES: | N#Cc1c(OC2C=CCCC2)c2ccccc2nc1N | InChi: | InChI=1S/C16H15N3O/c17-10-13-15(20-11-6-2-1-3-7-11)12-8-4-5-9-14(12)19-16(13)18/h2,4-6,8-9,11H,1,3,7H2,(H2,18,19)/t11-/m1/s1 | Definition date: | 2022-02-01 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-amino-4-{[(1S)-cyclohex-2-en-1-yl]oxy}quinoline-3-carbonitrile |
|
![JT9 JT9](https://data.pdbj.org/pdbjplus/data/cc/svg/JT9.svg) | JT9 | Name: | 3-{2-[(4S)-6,8-dichloro-5-methyl[1,2,4]triazolo[1,5-a]pyridin-2-yl]ethyl}quinoxalin-2(1H)-one | Formula: | C17 H13 Cl2 N5 O | SMILES: | O=C1Nc2ccccc2N=C1CCc1nc2c(Cl)cc(Cl)c(C)n2n1 | InChi: | InChI=1S/C17H13Cl2N5O/c1-9-10(18)8-11(19)16-22-15(23-24(9)16)7-6-14-17(25)21-13-5-3-2-4-12(13)20-14/h2-5,8H,6-7H2,1H3,(H,21,25) | Definition date: | 2022-02-01 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 3-{2-[(4S)-6,8-dichloro-5-methyl[1,2,4]triazolo[1,5-a]pyridin-2-yl]ethyl}quinoxalin-2(1H)-one |
|
![JTL JTL](https://data.pdbj.org/pdbjplus/data/cc/svg/JTL.svg) | JTL | Name: | N-[(thiophen-2-yl)methyl]quinoxaline-6-carboxamide | Formula: | C14 H11 N3 O S | SMILES: | O=C(NCc1cccs1)c1cc2nccnc2cc1 | InChi: | InChI=1S/C14H11N3OS/c18-14(17-9-11-2-1-7-19-11)10-3-4-12-13(8-10)16-6-5-15-12/h1-8H,9H2,(H,17,18) | Definition date: | 2022-02-01 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | N-[(thiophen-2-yl)methyl]quinoxaline-6-carboxamide |
|
![JU6 JU6](https://data.pdbj.org/pdbjplus/data/cc/svg/JU6.svg) | JU6 | Name: | (8S)-5-[(3S)-3-fluoropyrrolidin-1-yl]-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine | Formula: | C24 H26 F N7 O | SMILES: | FC1CCN(C1)c1cc(NC2CCOCC2)n2nc(cc2n1)c1nc2ccccc2nc1C | InChi: | InChI=1S/C24H26FN7O/c1-15-24(28-19-5-3-2-4-18(19)26-15)20-12-22-29-21(31-9-6-16(25)14-31)13-23(32(22)30-20)27-17-7-10-33-11-8-17/h2-5,12-13,16-17,27H,6-11,14H2,1H3 | Definition date: | 2022-02-01 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | (8S)-5-[(3S)-3-fluoropyrrolidin-1-yl]-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine |
|
![JUC JUC](https://data.pdbj.org/pdbjplus/data/cc/svg/JUC.svg) | JUC | Name: | (8R)-5-[(3R)-3-fluoropyrrolidin-1-yl]-N-methyl-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine | Formula: | C25 H28 F N7 O | SMILES: | CN(c1cc(nc2cc(nn12)c1nc2ccccc2nc1C)N1CCC(F)C1)C1CCOCC1 | InChi: | InChI=1S/C25H28FN7O/c1-16-25(28-20-6-4-3-5-19(20)27-16)21-13-23-29-22(32-10-7-17(26)15-32)14-24(33(23)30-21)31(2)18-8-11-34-12-9-18/h3-6,13-14,17-18H,7-12,15H2,1-2H3 | Definition date: | 2022-02-01 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | (8R)-5-[(3R)-3-fluoropyrrolidin-1-yl]-N-methyl-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine |
|
![JXO JXO](https://data.pdbj.org/pdbjplus/data/cc/svg/JXO.svg) | JXO | Name: | 6-chloroquinoxalin-2-amine | Formula: | C8 H6 Cl N3 | SMILES: | Clc1ccc2nc(N)cnc2c1 | InChi: | InChI=1S/C8H6ClN3/c9-5-1-2-6-7(3-5)11-4-8(10)12-6/h1-4H,(H2,10,12) | Definition date: | 2022-02-02 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 6-chloroquinoxalin-2-amine |
|
![JXX JXX](https://data.pdbj.org/pdbjplus/data/cc/svg/JXX.svg) | JXX | Name: | 2-chloro-4-(morpholin-4-yl)quinazoline | Formula: | C12 H12 Cl N3 O | SMILES: | Clc1nc(N2CCOCC2)c2ccccc2n1 | InChi: | InChI=1S/C12H12ClN3O/c13-12-14-10-4-2-1-3-9(10)11(15-12)16-5-7-17-8-6-16/h1-4H,5-8H2 | Definition date: | 2022-02-02 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-chloro-4-(morpholin-4-yl)quinazoline |
|
![K0C K0C](https://data.pdbj.org/pdbjplus/data/cc/svg/K0C.svg) | K0C | Name: | 2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-imidazo[4,5-f]quinoline | Formula: | C19 H18 N4 O S | SMILES: | Cc1c(OC)c(C)cnc1CSc1nc2ccc3ncccc3c2[NH]1 | InChi: | InChI=1S/C19H18N4OS/c1-11-9-21-16(12(2)18(11)24-3)10-25-19-22-15-7-6-14-13(17(15)23-19)5-4-8-20-14/h4-9H,10H2,1-3H3,(H,22,23) | Definition date: | 2022-02-02 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-imidazo[4,5-f]quinoline |
|
![K1X K1X](https://data.pdbj.org/pdbjplus/data/cc/svg/K1X.svg) | K1X | Name: | 3-[1-(quinolin-4-yl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one | Formula: | C23 H14 F3 N5 O2 | SMILES: | FC(F)(F)Oc1cccc(c1)N1C=CC(=O)C(=N1)c1ccnn1c1ccnc2ccccc12 | InChi: | InChI=1S/C23H14F3N5O2/c24-23(25,26)33-16-5-3-4-15(14-16)30-13-10-21(32)22(29-30)20-9-12-28-31(20)19-8-11-27-18-7-2-1-6-17(18)19/h1-14H | Definition date: | 2022-02-02 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 3-[1-(quinolin-4-yl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one |
|
![K63 K63](https://data.pdbj.org/pdbjplus/data/cc/svg/K63.svg) | K63 | Name: | N-[3-cyano-2-(2'-ethoxy[1,1'-biphenyl]-4-yl)-6-fluoroquinolin-4-yl]-D-alanine | Formula: | C27 H22 F N3 O3 | SMILES: | O=C(O)C(C)Nc1c2cc(F)ccc2nc(c1C#N)c1ccc(cc1)c1ccccc1OCC | InChi: | InChI=1S/C27H22FN3O3/c1-3-34-24-7-5-4-6-20(24)17-8-10-18(11-9-17)25-22(15-29)26(30-16(2)27(32)33)21-14-19(28)12-13-23(21)31-25/h4-14,16H,3H2,1-2H3,(H,30,31)(H,32,33)/t16-/m1/s1 | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | N-[3-cyano-2-(2'-ethoxy[1,1'-biphenyl]-4-yl)-6-fluoroquinolin-4-yl]-D-alanine |
|
![K6F K6F](https://data.pdbj.org/pdbjplus/data/cc/svg/K6F.svg) | K6F | Name: | 6-chloro-2,3-dimethylquinoxaline | Formula: | C10 H9 Cl N2 | SMILES: | Clc1cc2nc(C)c(C)nc2cc1 | InChi: | InChI=1S/C10H9ClN2/c1-6-7(2)13-10-5-8(11)3-4-9(10)12-6/h3-5H,1-2H3 | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 6-chloro-2,3-dimethylquinoxaline |
|
![IAY IAY](https://data.pdbj.org/pdbjplus/data/cc/svg/IAY.svg) | IAY | Name: | 4-(6-{2-[(4S)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]ethyl}pyridin-2-yl)morpholine | Formula: | C21 H26 N4 O | SMILES: | CN1CC(N=C1CCc1nc(ccc1)N1CCOCC1)c1ccccc1 | InChi: | InChI=1S/C21H26N4O/c1-24-16-19(17-6-3-2-4-7-17)23-20(24)11-10-18-8-5-9-21(22-18)25-12-14-26-15-13-25/h2-9,19H,10-16H2,1H3/t19-/m1/s1 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 4-(6-{2-[(4S)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]ethyl}pyridin-2-yl)morpholine |
|
![IBY IBY](https://data.pdbj.org/pdbjplus/data/cc/svg/IBY.svg) | IBY | Name: | 2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoline | Formula: | C21 H19 N3 | SMILES: | Cn1cc(nc1CCc1ccc2ccccc2n1)c1ccccc1 | InChi: | InChI=1S/C21H19N3/c1-24-15-20(16-7-3-2-4-8-16)23-21(24)14-13-18-12-11-17-9-5-6-10-19(17)22-18/h2-12,15H,13-14H2,1H3 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoline |
|
![ICQ ICQ](https://data.pdbj.org/pdbjplus/data/cc/svg/ICQ.svg) | ICQ | Name: | 2-[3-[4-(1~{H}-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-~{N}-propan-2-yl-ethanamide | Formula: | C26 H24 N6 O2 | SMILES: | CC(C)NC(=O)COc1cccc(c1)c2nc(Nc3ccc4[nH]ncc4c3)c5ccccc5n2 | InChi: | InChI=1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31) | Definition date: | 2022-03-10 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-[3-[4-(1~{H}-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-~{N}-propan-2-yl-ethanamide |
|
![IEU IEU](https://data.pdbj.org/pdbjplus/data/cc/svg/IEU.svg) | IEU | Name: | 6-chloro-2-{[(4S)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}-4-(morpholin-4-yl)quinazoline | Formula: | C23 H24 Cl N5 O2 | SMILES: | CN1CC(N=C1COc1nc(N2CCOCC2)c2cc(Cl)ccc2n1)c1ccccc1 | InChi: | InChI=1S/C23H24ClN5O2/c1-28-14-20(16-5-3-2-4-6-16)25-21(28)15-31-23-26-19-8-7-17(24)13-18(19)22(27-23)29-9-11-30-12-10-29/h2-8,13,20H,9-12,14-15H2,1H3/t20-/m1/s1 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 6-chloro-2-{[(4S)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}-4-(morpholin-4-yl)quinazoline |
|
![IEX IEX](https://data.pdbj.org/pdbjplus/data/cc/svg/IEX.svg) | IEX | Name: | 2-[2-(1,4-diphenyl-1H-imidazol-2-yl)ethyl]-3-methylquinoxaline | Formula: | C26 H22 N4 | SMILES: | Cc1nc2ccccc2nc1CCc1nc(cn1c1ccccc1)c1ccccc1 | InChi: | InChI=1S/C26H22N4/c1-19-22(28-24-15-9-8-14-23(24)27-19)16-17-26-29-25(20-10-4-2-5-11-20)18-30(26)21-12-6-3-7-13-21/h2-15,18H,16-17H2,1H3 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-[2-(1,4-diphenyl-1H-imidazol-2-yl)ethyl]-3-methylquinoxaline |
|
![IF2 IF2](https://data.pdbj.org/pdbjplus/data/cc/svg/IF2.svg) | IF2 | Name: | 2-methyl-3-{2-[1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl]ethyl}quinoxaline | Formula: | C18 H22 N6 | SMILES: | Cn1nc(nc1CCc1nc2ccccc2nc1C)N1CCCC1 | InChi: | InChI=1S/C18H22N6/c1-13-14(20-16-8-4-3-7-15(16)19-13)9-10-17-21-18(22-23(17)2)24-11-5-6-12-24/h3-4,7-8H,5-6,9-12H2,1-2H3 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-methyl-3-{2-[1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl]ethyl}quinoxaline |
|
![IFI IFI](https://data.pdbj.org/pdbjplus/data/cc/svg/IFI.svg) | IFI | Name: | 4-(azetidine-1-carbonyl)-1-methyl-N-[(4S)-2-(morpholin-4-yl)[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-5-carboxamide | Formula: | C19 H22 N8 O3 | SMILES: | O=C(N1CCC1)c1cnn(C)c1C(=O)Nc1cc2nc(nn2cc1)N1CCOCC1 | InChi: | InChI=1S/C19H22N8O3/c1-24-16(14(12-20-24)18(29)25-4-2-5-25)17(28)21-13-3-6-27-15(11-13)22-19(23-27)26-7-9-30-10-8-26/h3,6,11-12H,2,4-5,7-10H2,1H3,(H,21,28) | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 4-(azetidine-1-carbonyl)-1-methyl-N-[(4S)-2-(morpholin-4-yl)[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-5-carboxamide |
|
![IFY IFY](https://data.pdbj.org/pdbjplus/data/cc/svg/IFY.svg) | IFY | Name: | 2-methyl-3-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline | Formula: | C21 H20 N4 | SMILES: | Cn1cc(nc1CCc1nc2ccccc2nc1C)c1ccccc1 | InChi: | InChI=1S/C21H20N4/c1-15-17(23-19-11-7-6-10-18(19)22-15)12-13-21-24-20(14-25(21)2)16-8-4-3-5-9-16/h3-11,14H,12-13H2,1-2H3 | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-methyl-3-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline |
|
![IG9 IG9](https://data.pdbj.org/pdbjplus/data/cc/svg/IG9.svg) | IG9 | Name: | 4-(azetidine-1-carbonyl)-1-methyl-N-[1-(quinolin-2-yl)-1H-imidazol-4-yl]-1H-pyrazole-5-carboxamide | Formula: | C21 H19 N7 O2 | SMILES: | O=C(c1cnn(C)c1C(=O)Nc1cn(cn1)c1ccc2ccccc2n1)N1CCC1 | InChi: | InChI=1S/C21H19N7O2/c1-26-19(15(11-23-26)21(30)27-9-4-10-27)20(29)25-17-12-28(13-22-17)18-8-7-14-5-2-3-6-16(14)24-18/h2-3,5-8,11-13H,4,9-10H2,1H3,(H,25,29) | Definition date: | 2022-01-25 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 4-(azetidine-1-carbonyl)-1-methyl-N-[1-(quinolin-2-yl)-1H-imidazol-4-yl]-1H-pyrazole-5-carboxamide |
|
![K9F K9F](https://data.pdbj.org/pdbjplus/data/cc/svg/K9F.svg) | K9F | Name: | 5-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline | Formula: | C20 H18 N4 | SMILES: | Cn1cc(nc1CCc1cccc2nccnc12)c1ccccc1 | InChi: | InChI=1S/C20H18N4/c1-24-14-18(15-6-3-2-4-7-15)23-19(24)11-10-16-8-5-9-17-20(16)22-13-12-21-17/h2-9,12-14H,10-11H2,1H3 | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 5-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline |
|
![KA6 KA6](https://data.pdbj.org/pdbjplus/data/cc/svg/KA6.svg) | KA6 | Name: | 1-methyl-4-(morpholine-4-carbonyl)-N-[(4S)-2-(pyrrolidin-1-yl)[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-5-carboxamide | Formula: | C20 H24 N8 O3 | SMILES: | O=C(c1cnn(C)c1C(=O)Nc1cc2nc(nn2cc1)N1CCCC1)N1CCOCC1 | InChi: | InChI=1S/C20H24N8O3/c1-25-17(15(13-21-25)19(30)26-8-10-31-11-9-26)18(29)22-14-4-7-28-16(12-14)23-20(24-28)27-5-2-3-6-27/h4,7,12-13H,2-3,5-6,8-11H2,1H3,(H,22,29) | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 1-methyl-4-(morpholine-4-carbonyl)-N-[(4S)-2-(pyrrolidin-1-yl)[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1H-pyrazole-5-carboxamide |
|
![KB6 KB6](https://data.pdbj.org/pdbjplus/data/cc/svg/KB6.svg) | KB6 | Name: | 3-{2-[2-(4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy}isoquinoline | Formula: | C21 H17 F N2 O2 | SMILES: | Fc1ccc(cc1)c1nc(CCOc2cc3ccccc3cn2)c(C)o1 | InChi: | InChI=1S/C21H17FN2O2/c1-14-19(24-21(26-14)15-6-8-18(22)9-7-15)10-11-25-20-12-16-4-2-3-5-17(16)13-23-20/h2-9,12-13H,10-11H2,1H3 | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 3-{2-[2-(4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy}isoquinoline |
|
![KD4 KD4](https://data.pdbj.org/pdbjplus/data/cc/svg/KD4.svg) | KD4 | Name: | 2-chloro-5-methoxy-3-methylquinoxaline | Formula: | C10 H9 Cl N2 O | SMILES: | COc1cccc2nc(Cl)c(C)nc12 | InChi: | InChI=1S/C10H9ClN2O/c1-6-10(11)13-7-4-3-5-8(14-2)9(7)12-6/h3-5H,1-2H3 | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | 2-chloro-5-methoxy-3-methylquinoxaline |
|
![KH6 KH6](https://data.pdbj.org/pdbjplus/data/cc/svg/KH6.svg) | KH6 | Name: | N-[(4R)-6-cyano-2-phenylimidazo[1,2-a]pyridin-7-yl]-1-methyl-4-(morpholine-4-carbonyl)-1H-pyrazole-5-carboxamide | Formula: | C24 H21 N7 O3 | SMILES: | O=C(c1cnn(C)c1C(=O)Nc1cc2nc(cn2cc1C#N)c1ccccc1)N1CCOCC1 | InChi: | InChI=1S/C24H21N7O3/c1-29-22(18(13-26-29)24(33)30-7-9-34-10-8-30)23(32)28-19-11-21-27-20(16-5-3-2-4-6-16)15-31(21)14-17(19)12-25/h2-6,11,13-15H,7-10H2,1H3,(H,28,32) | Definition date: | 2022-02-03 | Last modified: | 2022-10-07 | Release date: | 2022-10-12 | Identifier: | N-[(4R)-6-cyano-2-phenylimidazo[1,2-a]pyridin-7-yl]-1-methyl-4-(morpholine-4-carbonyl)-1H-pyrazole-5-carboxamide |
|